An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

For patients with HPV16-positive CIN3, vaccination with a replication-incompetent Semliki Forest virus vaccine encoding HPV16 E6 and E7 is safe and shows clinical effectiveness.

But rates of types 31/33/45, 47, and 45 were lower in vaccinated women, which the authors said suggests that the vaccines ...

HPV is a group of viruses, and certain strains, such as HPV-16 and HPV-18, are responsible for nearly 70% of cervical cancer cases. HPV spreads through sexual contact and infects the cervix ...

ASHISH DESHMUKH: Yes. So it’s the most common sexually transmitted infection. There are more than 200 types of HPV, but types 16 and 18, they’re responsible for causing most cancer types. FLORA ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...